Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 8
1976 13
1977 24
1978 9
1979 10
1980 9
1981 11
1982 11
1983 19
1984 20
1985 33
1986 44
1987 57
1988 53
1989 35
1990 67
1991 47
1992 41
1993 47
1994 47
1995 63
1996 63
1997 61
1998 91
1999 145
2000 206
2001 230
2002 317
2003 387
2004 478
2005 482
2006 490
2007 490
2008 514
2009 578
2010 610
2011 739
2012 694
2013 746
2014 783
2015 698
2016 529
2017 413
2018 309
2019 106
2020 1
Text availability
Article attribute
Article type
Publication date

Search Results

9,856 results
Results by year
Filters applied: . Clear all
Page 1
Comparative effectiveness of aerosolized versus oral ribavirin for the treatment of respiratory syncytial virus infections: A single-center retrospective cohort study and review of the literature.
Trang TP, et al. Transpl Infect Dis 2018 - Review. PMID 29360277
In January 2015, our institution switched from aerosolized to oral ribavirin (RBV) for primary treatment of RSV infection among high-risk immunocompromised adult patients. ...
In January 2015, our institution switched from aerosolized to oral ribavirin (RBV) for primary treatment of RSV infection among high- …
Ribavirin for chronic hepatitis E virus infection in transplant recipients.
Kamar N, et al. N Engl J Med 2014 - Clinical Trial. PMID 24645943 Free article.
Patients received ribavirin for a median of 3 months (range, 1 to 18); 66% of the patients received ribavirin for 3 months or less. ...Anemia was the main identified side effect and required a reduction in ribavirin dose in 29% of the patients, the use of erythropoietin in 54%, and blood transfusions in 12%. ...
Patients received ribavirin for a median of 3 months (range, 1 to 18); 66% of the patients received ribavirin for 3 months or …
Systematic Review and Meta-analysis of Postexposure Prophylaxis for Crimean-Congo Hemorrhagic Fever Virus among Healthcare Workers
Ergönül Ö, et al. Emerg Infect Dis 2018. PMID 30124196 Free PMC article.
We performed a systematic review and meta-analysis on the effectiveness of ribavirin use for the prevention of infection and death of healthcare workers exposed to patients with Crimean-Congo hemorrhagic fever virus (CCHFV) infection. ...PEP with ribavirin reduced the odds of infection (OR 0.01, 95% CI 0-0.03), and ribavirin use <48 hours after symptom onset reduced the odds of death (OR 0.03, 95% CI 0-0.58). ...
We performed a systematic review and meta-analysis on the effectiveness of ribavirin use for the prevention of infection and d …
SARS: pharmacotherapy
Tsang K and Zhong NS. Respirology 2003 - Review. PMID 15018130
Although now considered lacking in efficacy, ribavirin was used extensively in Hong Kong for treatment of SARS. Retrospective data suggest that the use of Kaletra (ritonavir and lopinavir), an anti-protease, could reduce mortality and improve outcomes, although the adverse reactions are also worrisome. ...Other drug treatments had also been tried in desperate patients, including the use of convalescence serum and plasmapheresis. ...
Although now considered lacking in efficacy, ribavirin was used extensively in Hong Kong for treatment of SARS. Retrospective data su …
Ribavirin revisited in the era of direct-acting antiviral therapy for hepatitis C virus infection.
Feld JJ, et al. Liver Int 2017 - Review. PMID 27473533 Free PMC article.
The recent approvals of all-oral direct acting antivirals (DAAs) have revolutionized the HCV therapeutic landscape, and initially it was expected that the role of ribavirin with DAA regimens would be eliminated. ...Despite the antiviral mechanism of action of ribavirin being poorly understood, we now have a range of novel insights into the potential role of ribavirin in all-oral DAA HCV treatment and greater insight into the antiviral mechanism by which it continues to provide clinical benefit for defined patient groups....
The recent approvals of all-oral direct acting antivirals (DAAs) have revolutionized the HCV therapeutic landscape, and initially it …
Current practices for treatment of respiratory syncytial virus and other non-influenza respiratory viruses in high-risk patient populations: a survey of institutions in the Midwestern Respiratory Virus Collaborative
Beaird OE, et al. Transpl Infect Dis 2016. PMID 26923867
Eight of 12 centers used inhaled ribavirin (RBV) in some patient populations. Barriers included cost, safety, lack of evidence, and inconvenience. ...No consensus was found regarding the use of oral versus inhaled RBV, or the use of IVIG. The presence of such heterogeneity demonstrates the need for further studies defining optimal treatment of RSV in immunocompromised hosts....
Eight of 12 centers used inhaled ribavirin (RBV) in some patient populations. Barriers included cost, safety, lack of evidence, and i …
The utility of therapeutic drug monitoring for ribavirin in patients with chronic hepatitis C--a critical review.
Chan AH, et al. Ann Pharmacother 2009 - Review. PMID 19920162
OBJECTIVE: To evaluate the utility of therapeutic drug monitoring (TDM) for ribavirin in chronic hepatitis C. DATA SOURCES: Literature searches were conducted through PubMed (1949-June 2009), EMBASE (1980-June 2009), BIOSIS Previews (1969-June 2009), International Pharmaceutical Abstracts (1970-June 2009), Google, and www.clinicaltrials.gov using the terms ribavirin, therapeutic monitoring, hepatitis C, and drug levels. ...Studies that measured ribavirin concentrations or dose and treatment response were included in the review. DATA SYNTHESIS: While monitoring of ribavirin plasma concentrations to improve treatment response in patients with chronic hepatitis C has been described in the literature, the utility of TDM for ribavirin in this group of patients has not been systematically studied. ...
OBJECTIVE: To evaluate the utility of therapeutic drug monitoring (TDM) for ribavirin in chronic hepatitis C. DATA SOURCES: Li …
9,856 results
Jump to page
Feedback